PMC:1420271 / 10734-11310 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T6680 0-4 NN denotes ESG1
T6682 4-5 SYM denotes -
T6683 5-6 HYPH denotes /
T6684 6-7 SYM denotes -
T6685 8-10 NN denotes ES
T6681 11-16 NNS denotes cells
T6686 17-26 VBD denotes exhibited
T6687 27-33 JJ denotes normal
T6688 34-44 NN denotes morphology
T6689 45-46 -LRB- denotes (
T6691 46-52 NN denotes Figure
T6690 53-55 NN denotes 5A
T6692 55-56 -RRB- denotes )
T6693 56-57 . denotes .
T6694 57-180 sentence denotes These cells also proliferated at a speed comparable to that of the control (heterozygous and wild-type) cells (Figure 5B).
T6695 58-63 DT denotes These
T6696 64-69 NNS denotes cells
T6698 70-74 RB denotes also
T6697 75-87 VBD denotes proliferated
T6699 88-90 IN denotes at
T6700 91-92 DT denotes a
T6701 93-98 NN denotes speed
T6702 99-109 JJ denotes comparable
T6703 110-112 IN denotes to
T6704 113-117 DT denotes that
T6705 118-120 IN denotes of
T6706 121-124 DT denotes the
T6708 125-132 NN denotes control
T6709 133-134 -LRB- denotes (
T6710 134-146 JJ denotes heterozygous
T6711 147-150 CC denotes and
T6712 151-155 JJ denotes wild
T6714 155-156 HYPH denotes -
T6713 156-160 NN denotes type
T6715 160-161 -RRB- denotes )
T6707 162-167 NNS denotes cells
T6716 168-169 -LRB- denotes (
T6718 169-175 NN denotes Figure
T6717 176-178 NN denotes 5B
T6719 178-179 -RRB- denotes )
T6720 179-180 . denotes .
T6721 180-318 sentence denotes ESG1-/- cells differentiated normally after the removal of leukemia inhibitory factor (Figure 5B) or retinoic acid treatment (not shown).
T6722 181-185 NN denotes ESG1
T6724 185-186 SYM denotes -
T6725 186-187 HYPH denotes /
T6726 187-188 SYM denotes -
T6723 189-194 NNS denotes cells
T6727 195-209 VBD denotes differentiated
T6728 210-218 RB denotes normally
T6729 219-224 IN denotes after
T6730 225-228 DT denotes the
T6731 229-236 NN denotes removal
T6732 237-239 IN denotes of
T6733 240-248 NN denotes leukemia
T6735 249-259 JJ denotes inhibitory
T6734 260-266 NN denotes factor
T6736 267-268 -LRB- denotes (
T6738 268-274 NN denotes Figure
T6737 275-277 NN denotes 5B
T6739 277-278 -RRB- denotes )
T6740 279-281 CC denotes or
T6741 282-290 JJ denotes retinoic
T6743 291-295 NN denotes acid
T6742 296-305 NN denotes treatment
T6744 306-307 -LRB- denotes (
T6746 307-310 RB denotes not
T6745 311-316 VBN denotes shown
T6747 316-317 -RRB- denotes )
T6748 317-318 . denotes .
T6749 318-466 sentence denotes When transplanted into hind flanks of nude mice, these cells produced teratomas, tumors containing components of all three germ layers (Figure 5C).
T6750 319-323 WRB denotes When
T6751 324-336 VBN denotes transplanted
T6753 337-341 IN denotes into
T6754 342-346 NN denotes hind
T6755 347-353 NNS denotes flanks
T6756 354-356 IN denotes of
T6757 357-361 JJ denotes nude
T6758 362-366 NNS denotes mice
T6759 366-368 , denotes ,
T6760 368-373 DT denotes these
T6761 374-379 NNS denotes cells
T6752 380-388 VBD denotes produced
T6762 389-398 NNS denotes teratomas
T6763 398-400 , denotes ,
T6764 400-406 NNS denotes tumors
T6765 407-417 VBG denotes containing
T6766 418-428 NNS denotes components
T6767 429-431 IN denotes of
T6768 432-435 DT denotes all
T6770 436-441 CD denotes three
T6771 442-446 NN denotes germ
T6769 447-453 NNS denotes layers
T6772 454-455 -LRB- denotes (
T6774 455-461 NN denotes Figure
T6773 462-464 NN denotes 5C
T6775 464-465 -RRB- denotes )
T6776 465-466 . denotes .
T6777 466-576 sentence denotes These results indicate that ESG1 is dispensable for the self-renewal properties and pluripotency of ES cells.
T6778 467-472 DT denotes These
T6779 473-480 NNS denotes results
T6780 481-489 VBP denotes indicate
T6781 490-494 IN denotes that
T6783 495-499 NN denotes ESG1
T6782 500-502 VBZ denotes is
T6784 503-514 JJ denotes dispensable
T6785 515-518 IN denotes for
T6786 519-522 DT denotes the
T6788 523-527 NN denotes self
T6790 527-528 HYPH denotes -
T6789 528-535 NN denotes renewal
T6787 536-546 NNS denotes properties
T6791 547-550 CC denotes and
T6792 551-563 NN denotes pluripotency
T6793 564-566 IN denotes of
T6794 567-569 NN denotes ES
T6795 570-575 NNS denotes cells
T6796 575-576 . denotes .
R1529 T6680 T6681 nmod ESG1,cells
R1530 T6681 T6686 nsubj cells,exhibited
R1531 T6682 T6680 punct -,ESG1
R1532 T6683 T6680 punct /,ESG1
R1533 T6684 T6680 punct -,ESG1
R1534 T6685 T6681 compound ES,cells
R1535 T6687 T6688 amod normal,morphology
R1536 T6688 T6686 dobj morphology,exhibited
R1537 T6689 T6690 punct (,5A
R1538 T6690 T6686 parataxis 5A,exhibited
R1539 T6691 T6690 compound Figure,5A
R1540 T6692 T6690 punct ),5A
R1541 T6693 T6686 punct .,exhibited
R1542 T6695 T6696 det These,cells
R1543 T6696 T6697 nsubj cells,proliferated
R1544 T6698 T6697 advmod also,proliferated
R1545 T6699 T6697 prep at,proliferated
R1546 T6700 T6701 det a,speed
R1547 T6701 T6699 pobj speed,at
R1548 T6702 T6701 amod comparable,speed
R1549 T6703 T6702 prep to,comparable
R1550 T6704 T6703 pobj that,to
R1551 T6705 T6704 prep of,that
R1552 T6706 T6707 det the,cells
R1553 T6707 T6705 pobj cells,of
R1554 T6708 T6707 nmod control,cells
R1555 T6709 T6710 punct (,heterozygous
R1556 T6710 T6708 parataxis heterozygous,control
R1557 T6711 T6710 cc and,heterozygous
R1558 T6712 T6713 amod wild,type
R1559 T6713 T6710 conj type,heterozygous
R1560 T6714 T6713 punct -,type
R1561 T6715 T6710 punct ),heterozygous
R1562 T6716 T6717 punct (,5B
R1563 T6717 T6697 parataxis 5B,proliferated
R1564 T6718 T6717 compound Figure,5B
R1565 T6719 T6717 punct ),5B
R1566 T6720 T6697 punct .,proliferated
R1567 T6722 T6723 nmod ESG1,cells
R1568 T6723 T6727 nsubj cells,differentiated
R1569 T6724 T6722 punct -,ESG1
R1570 T6725 T6722 punct /,ESG1
R1571 T6726 T6722 punct -,ESG1
R1572 T6728 T6727 advmod normally,differentiated
R1573 T6729 T6727 prep after,differentiated
R1574 T6730 T6731 det the,removal
R1575 T6731 T6729 pobj removal,after
R1576 T6732 T6731 prep of,removal
R1577 T6733 T6734 nmod leukemia,factor
R1578 T6734 T6732 pobj factor,of
R1579 T6735 T6734 amod inhibitory,factor
R1580 T6736 T6737 punct (,5B
R1581 T6737 T6734 parataxis 5B,factor
R1582 T6738 T6737 compound Figure,5B
R1583 T6739 T6737 punct ),5B
R1584 T6740 T6731 cc or,removal
R1585 T6741 T6742 amod retinoic,treatment
R1586 T6742 T6731 conj treatment,removal
R1587 T6743 T6742 compound acid,treatment
R1588 T6744 T6745 punct (,shown
R1589 T6745 T6742 parataxis shown,treatment
R1590 T6746 T6745 neg not,shown
R1591 T6747 T6745 punct ),shown
R1592 T6748 T6727 punct .,differentiated
R1593 T6750 T6751 advmod When,transplanted
R1594 T6751 T6752 advcl transplanted,produced
R1595 T6753 T6751 prep into,transplanted
R1596 T6754 T6755 compound hind,flanks
R1597 T6755 T6753 pobj flanks,into
R1598 T6756 T6755 prep of,flanks
R1599 T6757 T6758 amod nude,mice
R1600 T6758 T6756 pobj mice,of
R1601 T6759 T6752 punct ", ",produced
R1602 T6760 T6761 det these,cells
R1603 T6761 T6752 nsubj cells,produced
R1604 T6762 T6752 dobj teratomas,produced
R1605 T6763 T6762 punct ", ",teratomas
R1606 T6764 T6762 appos tumors,teratomas
R1607 T6765 T6764 acl containing,tumors
R1608 T6766 T6765 dobj components,containing
R1609 T6767 T6766 prep of,components
R1610 T6768 T6769 det all,layers
R1611 T6769 T6767 pobj layers,of
R1612 T6770 T6769 nummod three,layers
R1613 T6771 T6769 compound germ,layers
R1614 T6772 T6773 punct (,5C
R1615 T6773 T6752 parataxis 5C,produced
R1616 T6774 T6773 compound Figure,5C
R1617 T6775 T6773 punct ),5C
R1618 T6776 T6752 punct .,produced
R1619 T6778 T6779 det These,results
R1620 T6779 T6780 nsubj results,indicate
R1621 T6781 T6782 mark that,is
R1622 T6782 T6780 ccomp is,indicate
R1623 T6783 T6782 nsubj ESG1,is
R1624 T6784 T6782 acomp dispensable,is
R1625 T6785 T6784 prep for,dispensable
R1626 T6786 T6787 det the,properties
R1627 T6787 T6785 pobj properties,for
R1628 T6788 T6789 compound self,renewal
R1629 T6789 T6787 compound renewal,properties
R1630 T6790 T6789 punct -,renewal
R1631 T6791 T6787 cc and,properties
R1632 T6792 T6787 conj pluripotency,properties
R1633 T6793 T6792 prep of,pluripotency
R1634 T6794 T6795 compound ES,cells
R1635 T6795 T6793 pobj cells,of
R1636 T6796 T6780 punct .,indicate